Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 3
1989 4
1990 6
1991 17
1992 18
1993 22
1994 36
1995 20
1996 48
1997 35
1998 24
1999 23
2000 32
2001 22
2002 26
2003 32
2004 35
2005 30
2006 30
2007 27
2008 25
2009 28
2010 32
2011 28
2012 32
2013 38
2014 46
2015 40
2016 45
2017 53
2018 52
2019 43
2020 27
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

900 results
Results by year
Filters applied: . Clear all
Page 1
Epidermolysis bullosa: Advances in research and treatment.
Prodinger C, Reichelt J, Bauer JW, Laimer M. Prodinger C, et al. Exp Dermatol. 2019 Oct;28(10):1176-1189. doi: 10.1111/exd.13979. Epub 2019 Aug 8. Exp Dermatol. 2019. PMID: 31140655 Free PMC article. Review.
We are evaluating immunotherapy using an anti-PD1 monoclonal antibody as a palliative treatment option for locally advanced or metastatic squamous cell carcinoma of the skin unresponsive to previous systemic therapy. In addition, we are evaluating topical calcipotriol and …
We are evaluating immunotherapy using an anti-PD1 monoclonal antibody as a palliative treatment option for locally advanced or metastatic sq …
The Evolution of Topical Formulations in Psoriasis.
Kuehl B, Shear NH. Kuehl B, et al. Skin Therapy Lett. 2018 Jul;23(4):5-9. Skin Therapy Lett. 2018. PMID: 30086183 Free article. Review.
Well-designed foam vehicles are easily spread over large areas of the skin, while importantly not leaving a greasy or oily film on the skin after application. Calcipotriol/betamethasone diproprionate aerosol foam is a new psoriasis treatment option that is rapidly effectiv …
Well-designed foam vehicles are easily spread over large areas of the skin, while importantly not leaving a greasy or oily film on the skin …
Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.
McCormack PL. McCormack PL. Am J Clin Dermatol. 2011 Dec 1;12(6):421-4. doi: 10.2165/11207670-000000000-00000. Am J Clin Dermatol. 2011. PMID: 21967117 Review.
Calcipotriene (calcipotriol)/betamethasone dipropionate (calcipotriene 50 mug/g and betamethasone 0.5 mg/g) is a fixed-dose combination of a vitamin D3 analog and a corticosteroid indicated for the once-daily, topical treatment of psoriasis vulgaris of the tr
Calcipotriene (calcipotriol)/betamethasone dipropionate (calcipotriene 50 mug/g and betamethasone 0.5 mg/g) is a fixed-
Skin cancer precursor immunotherapy for squamous cell carcinoma prevention.
Rosenberg AR, Tabacchi M, Ngo KH, Wallendorf M, Rosman IS, Cornelius LA, Demehri S. Rosenberg AR, et al. JCI Insight. 2019 Mar 21;4(6):e125476. doi: 10.1172/jci.insight.125476. eCollection 2019 Mar 21. JCI Insight. 2019. PMID: 30895944 Free PMC article. Clinical Trial.
However, the long-term effectiveness of calcipotriol plus 5-FU treatment for SCC prevention is unknown. METHODS: We performed a blinded prospective cohort study on participants of a randomized double-blind clinical trial in which a 4-day course of topical calcipotriol
However, the long-term effectiveness of calcipotriol plus 5-FU treatment for SCC prevention is unknown. METHODS: We performed a blind …
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Cunningham TJ, Tabacchi M, Eliane JP, Tuchayi SM, Manivasagam S, Mirzaalian H, Turkoz A, Kopan R, Schaffer A, Saavedra AP, Wallendorf M, Cornelius LA, Demehri S. Cunningham TJ, et al. J Clin Invest. 2017 Jan 3;127(1):106-116. doi: 10.1172/JCI89820. Epub 2016 Nov 21. J Clin Invest. 2017. PMID: 27869649 Free PMC article. Clinical Trial.
METHODS: The mechanism of calcipotriol action against skin carcinogenesis was examined in genetically engineered mouse models. ...Four-day application of calcipotriol plus 5-FU versus Vaseline plus 5-FU led to an 87.8% versus 26.3% mean reduction in the number of ac …
METHODS: The mechanism of calcipotriol action against skin carcinogenesis was examined in genetically engineered mouse models. ...Fou …
Topical calcipotriol/betamethasone dipropionate for psoriasis vulgaris: A systematic review.
Yan R, Jiang S, Wu Y, Gao XH, Chen HD. Yan R, et al. Indian J Dermatol Venereol Leprol. 2016 Mar-Apr;82(2):135-44. doi: 10.4103/0378-6323.175919. Indian J Dermatol Venereol Leprol. 2016. PMID: 26924402 Free article. Review.
The methodologies of the studies were generally of moderate to high quality. These trials used topical calcipotriol/betamethasone dipropionate for 4 or 8 weeks, and were compared with topical calcipotriol or betamethasone. ...The adverse events of calcipotriol
The methodologies of the studies were generally of moderate to high quality. These trials used topical calcipotriol/betamethasone dip …
Neutralization of IL-17C Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic Dermatitis.
Vandeghinste N, Klattig J, Jagerschmidt C, Lavazais S, Marsais F, Haas JD, Auberval M, Lauffer F, Moran T, Ongenaert M, Van Balen M, Dupont S, Lepescheux L, Garcia T, Härtle S, Eyerich K, Fallon PG, Brys R, Steidl S. Vandeghinste N, et al. J Invest Dermatol. 2018 Jul;138(7):1555-1563. doi: 10.1016/j.jid.2018.01.036. Epub 2018 Feb 21. J Invest Dermatol. 2018. PMID: 29474945 Free article.
To determine the contribution of IL-17C to AD pathogenesis, MOR106 was tested in two distinct in vivo models. In the calcipotriol-induced AD model, ear skin inflammation, TSLP, and IL-33 protein production in ears was suppressed by MOR106. ...
To determine the contribution of IL-17C to AD pathogenesis, MOR106 was tested in two distinct in vivo models. In the calcipotriol-ind …
Calcipotriene betamethasone dipropionate aerosol foam in the treatment of plaque psoriasis: a review of the literature.
Frieder J, Kivelevitch D, Menter A. Frieder J, et al. Ther Deliv. 2017 Aug;8(9):737-746. doi: 10.4155/tde-2017-0058. Epub 2017 Jun 29. Ther Deliv. 2017. PMID: 28659016 Review.
Mainstay topical treatments include corticosteroids and vitamin D derivatives. Calcipotriene/betamethasone dipropionate aerosol foam is a novel single product combination, which seeks to provide superior therapeutic efficacy in addition to enhanced cosmetic properties. Thi …
Mainstay topical treatments include corticosteroids and vitamin D derivatives. Calcipotriene/betamethasone dipropionate aerosol foam …
Topical application of calcipotriene and corticosteroids: combination regimens.
Lebwohl M. Lebwohl M. J Am Acad Dermatol. 1997 Sep;37(3 Pt 2):S55-8. J Am Acad Dermatol. 1997. PMID: 9344186 Review.
BACKGROUND: Side effects of topical corticosteroids limit their long-term use. Calcipotriene/calcipotriol (Dovonex/Daivonex) ointment is not associated with any of the side effects of corticosteroids and has been shown to thicken the skin in contrast to the cutaneou …
BACKGROUND: Side effects of topical corticosteroids limit their long-term use. Calcipotriene/calcipotriol (Dovonex/Daivonex) o …
The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis.
Thiers BH. Thiers BH. J Am Acad Dermatol. 1997 Sep;37(3 Pt 2):S69-71. J Am Acad Dermatol. 1997. PMID: 9344189 Review.
BACKGROUND: Topical calcipotriene ointment has been approved for the treatment of plaque-type psoriasis. ...RESULTS: Recent reports suggest that certain ichthyoses (particularly the hyperproliferative variants) and keratodermas may respond to topical calcipotriene o …
BACKGROUND: Topical calcipotriene ointment has been approved for the treatment of plaque-type psoriasis. ...RESULTS: Recent reports s …
900 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page